Epilepsy is a well-known neurological disease, found in about 3% of the population.
Approximately 30% of patients with epilepsy do not respond to currently available therapies …

4,181,803 A 1, 1980 Morita et al. 4,554.281 A 11/1985 vonBebenburg et al. 4,668,684 A 5,
1987 Tibes et al. 4,778,799 A 10, 1988 Tibes et al. 4,923,858 A 5/1990 Engel et al …

(R) is useful in the treatment and prevention of a disorder Such as cachexia, stroke,
atherosclerosis, coronary artery disease, and diabetes and pharmaceutical compositions of …

The invention relates to methods for diagnosing bone disorders and/or cardiovascular
disorders in a subject, by contacting a biological sample from the subject with (a) a nucleic …

Disclosed herein are compositions and methods for treating a psychiatric disorder or
symptoms thereof in a patient. The compositions comprise a compound that modulates …

4,181,803 A 1, 1980 Morita et al. 4,554.281 A 11/1985 vonBebenburg et al. 4,668,684 A 5,
1987 Tibes et al. 4,778,799 A 10, 1988 Tibes et al. 4,923,858 A 5/1990 Engel et al …

Potassium channels form the largest group of ion channels in the human genome, with
approximately 78 pore-forming 'alpha'subunits and 13 auxiliary 'beta'subunits identified to …

This application is a divisional application of Ser. No. 12/491,055, filed on Jun. 24, 2009,
now US Pat. No. 8,188, 314, which claims the benefit of priority of US provisional application …

US20100323987A1 - Combinations of retigabine and sodium channel inhibitors or sodium
channel-influencing active compounds for treating pains - Google Patents …

A6II 3/167(2006.01) CD7C 23.3/0(2006.01) C07C 27I/28(2006.01) CD7C 33.3/08(2006.01)
C07D 239/02(2006.01) C07D 213/63(2006.01) C07D 33.3/02(2006.01) C07D …